NCT06537700View on ClinicalTrials.gov

OnaBotulinumtoxin-A in Chronic Migraine Patients with Short or Long Disease History (the BACH Study)

RecruitingOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Migraine
Interventions
DRUG

OnabotulinumtoxinA OBT-A

Patients will be re-evaluated every 3 months, at each OBT-A cycle, during the whole year of treatment. Every evaluation patients will show their diary of headaches with monthly migraine and headache days and acute medications taken.

Trial Locations (6)

Unknown

RECRUITING

Università Politecnica delle Marche, Ancona

RECRUITING

Università Studi dell'Aquila, L’Aquila

RECRUITING

IRCCS Istituto Auxologico Italiano, Milan

RECRUITING

Istituto Neurologico Besta, Milan

RECRUITING

Policlinico Tor Vergata, Roma

00128

RECRUITING

Fondazione Policlinico Campus Bio-Medico, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER